(BNR) Brenntag SE - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A1DAHH0
BNR: Industrial Chemicals, Specialty Chemicals, Ingredients
Brenntag SE is a global leader in chemical distribution, operating across Europe, the Middle East, Africa, the Americas, and the Asia Pacific. Founded in 1874 and headquartered in Essen, Germany, the company has built a robust platform for sourcing, storing, and delivering industrial and specialty chemicals. Brenntag operates through two core segments: Brenntag Essentials, which focuses on industrial chemicals, and Brenntag Specialties, which caters to higher-margin specialty chemicals. This dual approach allows the company to balance volume-driven industrial sales with the precision and customization required for specialty markets.
The company’s value proposition lies in its ability to provide end-to-end solutions for chemical distribution. Brenntag offers just-in-time delivery, product mixing, blending, and repackaging, as well as inventory management and drum return handling. This comprehensive service model is critical for industries where supply chain efficiency and product handling are paramount. Brenntag serves a diverse range of end markets, including nutrition, pharma, personal care, water treatment, and lubricants, as well as home, industrial, and institutional markets. It also has a strong presence in coatings, constructions, polymers, and rubber industries.
From a financial perspective, Brenntag SE is a large-cap company with a market capitalization of 8,683.31 million EUR. The stock trades on the XETRA exchange under the ticker symbol BNR. The company’s trailing P/E ratio of 14.63 and forward P/E of 10.86 suggest that investors are pricing in moderate growth expectations. The price-to-book ratio of 2.00 indicates that the market values the company’s assets at a premium, likely due to its strong distribution network and intangible assets like customer relationships. The price-to-sales ratio of 0.54 reflects the company’s ability to generate revenue from its extensive operations.
For investors and fund managers, Brenntag SE’s appeal lies in its stable cash flows, driven by long-term contracts with suppliers and customers. The company’s scale and global reach provide a competitive advantage, as it can negotiate favorable terms with chemical manufacturers and pass economies of scale to its customers. Brenntag’s focus on sustainability and safety in chemical handling also aligns with the growing emphasis on ESG criteria in investment decisions. However, the company’s profitability is sensitive to fluctuations in chemical prices and global demand, making it important to monitor macroeconomic trends and industry dynamics.
Additional Sources for BNR Stock
BNR Stock Overview
Market Cap in USD | 9,566m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
BNR Stock Ratings
Growth 5y | 20.3% |
Fundamental | 33.2% |
Dividend | 92.8% |
Rel. Strength | -17.7 |
Analysts | - |
Fair Price Momentum | 57.93 EUR |
Fair Price DCF | 90.33 EUR |
BNR Dividends
Dividend Yield 12m | 6.81% |
Yield on Cost 5y | 13.12% |
Annual Growth 5y | 10.93% |
Payout Consistency | 100.0% |
BNR Growth Ratios
Growth Correlation 3m | 65.6% |
Growth Correlation 12m | -63.7% |
Growth Correlation 5y | 27.9% |
CAGR 5y | 12.90% |
CAGR/Max DD 5y | 0.37 |
Sharpe Ratio 12m | -0.74 |
Alpha | -28.66 |
Beta | 0.894 |
Volatility | 32.47% |
Current Volume | 243.5k |
Average Volume 20d | 294.7k |
As of April 03, 2025, the stock is trading at EUR 59.26 with a total of 243,498 shares traded.
Over the past week, the price has changed by -4.94%, over one month by -8.27%, over three months by +1.13% and over the past year by -20.95%.
Neither. Based on ValueRay Fundamental Analyses, Brenntag SE is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 33.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNR as of April 2025 is 57.93. This means that BNR is currently overvalued and has a potential downside of -2.24%.
Brenntag SE has no consensus analysts rating.
According to ValueRays Forecast Model, BNR Brenntag SE will be worth about 64.1 in April 2026. The stock is currently trading at 59.26. This means that the stock has a potential upside of +8.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 74.6 | 25.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 64.1 | 8.1% |